Ozempic: Key differences Here are a few key differences between the drugs: Primary indication and FDA approval Contrave The FDA has approved Contrave for long-term weight management in adults who meet specific BMI requirements: A body mass index (BMI) of 30 kg/m or higher (obesity), or A BMI of 27 kg/m or higher (overweight), plus at least one weight-related medical condition, such as high blood pressure, type 2 diabetes, or high cholesterol (dyslipidemia) Ozempic Ozempic is FDA-approved for: Controlling blood sugar in adults with type 2 diabetes Reducing the risk of serious heart problems, like heart attack, stroke, and death, in adults with type 2 diabetes and heart disease Reducing the risk of worsening kidney disease and cardiovascular death in adults with type 2 diabetes and chronic kidney disease Although Ozempic isnt FDA-approved for weight loss, your healthcare provider may prescribe it off-label to help with weight management
The biomarkers of interest include the hippocampal volume, as determined through MRI and based on CSF and plasma pTau181 levels
It may support patients interested in weight management as part of a structured care plan
Injecting before dinner means the appetite-suppressing effects begin building during your meal
All-Inclusive Weekly Program Best Value Prescription Semaglutide injections (provider-guided) Weekly check-ins & progress tracking Dose titration for results without crazy side effects Nutrition guardrails you can actually follow Text support for quick questions between visits Typical results vary by individual
